Edition:
United States

Allergan plc (AGN)

AGN on New York Consolidated

243.27USD
24 Aug 2016
Change (% chg)

$-9.94 (-3.93%)
Prev Close
$253.21
Open
$254.00
Day's High
$254.90
Day's Low
$240.86
Volume
4,530,727
Avg. Vol
3,453,665
52-wk High
$322.68
52-wk Low
$240.86

Select another date:

Tue, Aug 16 2016

Photo

Icahn makes new bet on Allergan in second-quarter: filing

BOSTON Carl Icahn, the octogenarian investor whose stock investments still create a buzz on Wall Street nearly 50 years after he first got into the business, made a new bet on Allergan, a new filing shows.

BRIEF-Greenlight Capital dissolves share stake in Allergan Plc - SEC filing

* Greenlight Capital Inc dissolves share stake in Allergan Plc

BRIEF-Omega Advisors dissolves share stake in Apple, raises share stake in Allergan

* Omega Advisors takes 1.49 million shares stake in Nabors Industries Ltd - SEC filing

BRIEF-Omega Advisors cuts in Motorola Solutions, ups in Allergan

* Omega Advisors Inc Ups Share Stake In Allergan Plc By 19.6 Pct To 671,212

BRIEF-Appaloosa LP ups share stake in Allergan, cuts in Ingersoll-Rand

* Appaloosa LP ups share stake in Allergan Plc to 1.3 Mln from 279,109 Shares - SEC filing

BRIEF-Allergan to acquire eye care company Forsight Vision5

* Allergan to acquire eye care company Forsight Vision5 adding Peri-Ocular Ring Technology to company's leading portfolio of innovative eye health products

Allergan focused on 'stepping stone' deals, not big ones like Biogen

Allergan Plc's chief executive officer said on Monday he is not interested in using the drugmaker's cash pile for big deals, one week after selling its generics business for $40.5 billion.

UPDATE 3-Allergan focused on 'stepping stone' deals, not big ones like Biogen

Aug 8 Allergan Plc's chief executive officer said on Monday he is not interested in using the drugmaker's cash pile for big deals, one week after selling its generics business for $40.5 billion.

BRIEF-Allergan reports Q2 non-GAAP earnings per share of $3.35

* Allergan reports strong second quarter 2016 continuing operations performance with net revenues of $3.7 billion

Select another date: